WS #1529
The data dump reveals escalating geopolitical tensions in the Middle East as the dominant market-moving signal, with significant implications for energy markets and broader risk sentiment. Israel's reported assassination of Iran's Intelligence Minister Esmail Khatib, corroborated by multiple sources including Al Jazeera, NBC, and social media posts, marks the third high-profile killing of Iranian leaders in two days, increasing the risk of retaliatory actions that could further disrupt oil supply routes. Concurrently, reports indicate that approximately 90 ships, including oil tankers, have crossed the Strait of Hormuz despite the conflict, suggesting Iran's oil exports continue at near-pre-war levels, which may temporarily ease supply fears but underscores the volatility of the situation. Diplomatic strains are evident, with France offering conditional help to secure the strait and Trump's calls for international assistance being declined, while regional meetings like the GCC+ gathering in Riyadh aim to coordinate responses. In corporate news, Macy's Q4 earnings beat estimates but showed year-over-year declines, with cautious FY2026 guidance citing macroeconomic and geopolitical factors that could impact discretionary spending, reflecting broader retail sector challenges. Protalix BioTherapeutics reported a significant Q4 miss on both EPS and sales, though it provided a FY26 revenue outlook that includes a $25 million milestone, indicating mixed sentiment for the biotech sector. The AI infrastructure sector shows continued momentum with positive coverage for Marvell Technology and Oracle, though class action lawsuits against Oracle, Snowflake, and BlackRock introduce legal risks that could affect investor sentiment. Other developments, such as a meningitis outbreak declared a national incident in London and routine SEC filings, are considered noise with limited immediate market impact.
Key developments
- Israel assassinates Iran's intelligence minister, escalating Middle East tensions
- Oil shipments continue through Strait of Hormuz despite conflict, easing supply fears
- Macy's beats Q4 estimates but issues cautious FY2026 guidance citing geopolitical risks
- Protalix BioTherapeutics misses Q4 estimates significantly
- Class action lawsuits filed against Oracle, Snowflake, and BlackRock